Serum Lipids, Recent Suicide Attempt and Recent Suicide Status in Patients with Major Depressive Disorder
Overview
Authors
Affiliations
Objective: Major depressive disorder (MDD) is associated with suicide. Although several studies have reported its association with low serum lipid, few studies have investigated relationships between current suicidality and lipid profiles, comparing with other blood measures in MDD patients.
Methods: The study population consisted of 555 subjects with MDD who were ≥ 18 years old, evaluated by the Mini International Neuropsychiatric Interview (MINI) with the suicidality module. At the evaluation visit, we measured serum lipid profiles including total cholesterol, triglycerides (TG), low-density lipoprotein (LDL), high-density lipoprotein (HDL), and very low-density lipoprotein (VLDL), and blood measures such as fasting glucose, total protein, albumin, blood urea nitrogen, creatinine, thyroid hormones, red and white blood cells, platelet count, hemoglobin, and hematocrit.
Results: Recent attempters who had attempted suicide within the past month showed significantly lower TG and higher HDL levels than lifetime and never attempters, using Tukey's post-hoc analysis. Recent attempters exhibited lower TG and higher HDL than those with recent suicide ideation and wish to self-harm and those without previous attempt. Linear regression analysis revealed that TG was negatively associated with current suicidality scores (β = -0.187, p = 0.039), whereas VLDL was positively associated with the recent suicide status (β = 0.198, p = 0.032) after controlling for age and sex. There were no significant differences between the groups in terms of other serum lipid profiles and blood measures.
Conclusions: Low serum TG, high HDL and VLDL levels are associated with recent suicide attempt or recent suicide status in patients with MDD.
He Y, Wei Y, Wang Y, Liang F, Ma T Front Psychiatry. 2024; 15:1359400.
PMID: 39119074 PMC: 11306130. DOI: 10.3389/fpsyt.2024.1359400.
Tian X, Liu X, Bai F, Li M, Qiu Y, Jiao Q Brain Behav. 2024; 14(6):e3578.
PMID: 38844426 PMC: 11156525. DOI: 10.1002/brb3.3578.
Yin H, Lu B, Zeng K, Li Y, Ma J BMC Psychiatry. 2024; 24(1):396.
PMID: 38802840 PMC: 11131298. DOI: 10.1186/s12888-024-05848-3.
Daray F, Chiapella L, Grendas L, Alvarez Casiani R, Olaviaga A, Robetto J Mol Psychiatry. 2024; 29(12):3874-3892.
PMID: 38802507 DOI: 10.1038/s41380-024-02587-5.
Yuan D, Wu J, Li S, Zhou X, Zhang R, Zhang Y Heliyon. 2024; 10(9):e30718.
PMID: 38765065 PMC: 11098842. DOI: 10.1016/j.heliyon.2024.e30718.